Skip to main content

9 Result(s)

within A.-S. Michallet Remove this filter

and

  1. Article

    Open Access

    Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial

    Efficacy of lenalidomide was investigated in 103 patients with relapsed/refractory chronic lymphocytic leukemia (CLL) treated on the prospective, multicenter randomized phase-II CLL-009 trial. Interphase cytog...

    A Bühler, C-M Wendtner, T J Kipps, L Rassenti, G A M Fraser… in Blood Cancer Journal (2016)

    Download PDF (370 KB) View Article

  2. No Access

    Article

    Intolérance à l’effort de la personne obèse : modalités d’évaluation et conséquences pour la prescription de l’activité physique

    L’activité physique est un adjuvant important dans la prise en charge de la personne obèse. Toutefois, l’obésité est souvent associée à une intolérance à l’effort. L’objectif de cet article didactique est de c...

    M. Mendelson, A. S. Michallet, J. Tonini, A. Favre-Juvin, M. Guinot… in Obésité (2012)

  3. No Access

    Article

    Activité physique dans la prise en charge de l’obésité : effets bénéfiques et modalités pratiques

    L’activité physique régulière constitue une modalité importante de la prise en charge de l’obésité en participant à la diminution de la morbidité cardio-vasculaire et métabolique. Cet article didactique se foc...

    M. Mendelson, A. S. Michallet, J. Tonini, M. Guinot, V. A. Bricout, P. Flore in Obésité (2012)

  4. No Access

    Article

    Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia

    We report our experience on rituximab–cyclophosphamide–dexamethasone (RCD) combination therapy for the treatment of autoimmune disorders (AIDs) in 48 chronic lymphocytic leukemia (CLL) patients. Overall, 81% o...

    J Rossignol, A-S Michallet, L Oberic, M Picard, A Garon, C Willekens, R Dulery… in Leukemia (2011)

  5. No Access

    Article

    La transplantation pulmonaire: avant, pendant et après… — Spécificités de la prise en charge sur la liste d’attente

    A. Houssière, A. -S. Michallet in Réanimation (2011)

  6. No Access

    Article

    Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT)

    In order to study efficacy, toxicity and the long-term results of donor lymphocyte infusions (DLI), we retrospectively analyzed DLI given for relapse after conventional allogeneic hematopoietic stem cell trans...

    A S Michallet, F Nicolini, S Fürst, Q H Le, V Dubois… in Bone Marrow Transplantation (2005)

  7. No Access

    Article

    Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

    In all, 41 multiple myeloma (MM) patients received an antithymocyte globulin (ATG), fludarabine, and busulfan-based reduced intensity conditioning (RIC) for allogeneic stem cell transplantation (allo-SCT) from...

    M Mohty, J M Boiron, G Damaj, A S Michallet, J O Bay… in Bone Marrow Transplantation (2004)

  8. No Access

    Article

    Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation

    T Prebet, A-S Michallet, C Charrin, S Hayette, J-P Magaud… in Bone Marrow Transplantation (2004)

  9. No Access

    Article

    T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome

    <p>Nijmegen breakage syndrome (NBS) is characterized by growth retardation, microcephaly, mental retardation, immunodeficiency, and predisposition to malignancies, especially B-cell lymphomas. In contrast, leu...

    A.-S. Michallet, G. Lesca, I. Radford-Weiss, R. Delarue, B. Varet… in Annals of Hematology (2003)